Tri Locum Partners’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-101,959
| Closed | -$3.98M | – | 27 |
|
|
2024
Q2 | $3.98M | Sell |
101,959
-105,506
| -51% | -$4.11M | 1.01% | 20 |
|
|
2024
Q1 | $8.93M | Sell |
207,465
-18,099
| -8% | -$779K | 3.1% | 14 |
|
|
2023
Q4 | $10.4M | Buy |
225,564
+53,809
| +31% | +$2.48M | 4.75% | 10 |
|
|
2023
Q3 | $5.87M | Buy |
171,755
+147,534
| +609% | +$5.04M | 1.88% | 18 |
|
|
2023
Q2 | $933K | Sell |
24,221
-197,509
| -89% | -$7.6M | 0.35% | 37 |
|
|
2023
Q1 | $7.94M | Buy |
221,730
+128,366
| +137% | +$4.59M | 2.42% | 16 |
|
|
2022
Q4 | $3.68M | Sell |
93,364
-40,967
| -30% | -$1.62M | 1.49% | 21 |
|
|
2022
Q3 | $4.85M | Sell |
134,331
-32,068
| -19% | -$1.16M | 1.33% | 26 |
|
|
2022
Q2 | $5.06M | Buy |
+166,399
| New | +$5.06M | 2.07% | 19 |
|
|
2022
Q1 | – | Sell |
-25,043
| Closed | -$782K | – | 50 |
|
|
2021
Q4 | $782K | Sell |
25,043
-239,091
| -91% | -$7.47M | 0.31% | 34 |
|
|
2021
Q3 | $4.04M | Buy |
+264,134
| New | +$4.04M | 1.6% | 17 |
|